Fortress Biotech (FBIO) Profit After Tax (2010 - 2026)

Fortress Biotech's Profit After Tax history runs 16 years deep, the most recent figure standing at $34.3 million for Q4 2025.

• In Q4 2025, Profit After Tax rose 230.47% year-over-year to $34.3 million; the TTM figure through Dec 2025 stood at $45.1 million (up 143.78% YoY), while the FY2025 annual figure was $6.8 million, up 105.64% from the prior year.
• Profit After Tax for Q4 2025 stood at $34.3 million, up from $5.8 million in the prior quarter.
• The five-year high for Profit After Tax was $34.3 million in Q4 2025, with the low at -$59.3 million in Q2 2023.
• The 5-year median for Profit After Tax is -$23.0 million (2021), against an average of -$21.8 million.
• The sharpest annual moves came in 2023 and 2025: Profit After Tax sank 177.11% in 2023, then surged 241.45% in 2025.
• Fortress Biotech's Profit After Tax stood at -$31.6 million in 2021, then tumbled by 81.99% to -$57.4 million in 2022, then soared by 49.54% to -$29.0 million in 2023, then increased by 9.21% to -$26.3 million in 2024, then surged by 230.47% to $34.3 million in 2025.
• Business Quant data shows FBIO's Profit After Tax at $34.3 million in Q4 2025, $5.8 million in Q3 2025, and $15.5 million in Q2 2025.